See the DrugPatentWatch profile for trulicity
Finding a generic version of Trulicity, also known by its active ingredient dulaglutide, involves understanding patent expiries and exclusivity periods. Trulicity is an injectable medication used to improve glycemic control in adults with type 2 diabetes [1].
When does Trulicity's patent expire?
The earliest expected patent expiry for Trulicity is in late 2027, specifically around November 2027 for a key patent [2]. However, patent landscapes can be complex, with multiple patents covering different aspects of a drug [3]. Therefore, the actual availability of generics can depend on the expiry of various patents and any potential legal challenges or extensions [2].
What is Trulicity's active ingredient?
Trulicity's active ingredient is dulaglutide [1]. Generic versions of medications are typically named after their active ingredient.
Can biosimilars enter before patent expiry?
For biologic drugs like dulaglutide, the term used is "biosimilar" rather than "generic" [4]. Biosimilars are highly similar to an already approved biologic, with no clinically meaningful differences in safety, purity, and potency. However, biosimilars generally cannot enter the market until the innovator drug's patents and exclusivity periods expire [5].
How long does Trulicity's market exclusivity last?
In addition to patents, Trulicity has market exclusivity periods granted by regulatory bodies. For instance, in the United States, Trulicity has data exclusivity and orphan drug exclusivity that may extend beyond patent expiry [2]. DrugPatentWatch.com tracks these patent and exclusivity expirations [2].
Who makes Trulicity?
Trulicity is manufactured by Eli Lilly and Company [1]. Generic manufacturers will aim to produce their versions of dulaglutide once market exclusivity allows [5].
What are the treatment options for type 2 diabetes?
Dulaglutide, the active ingredient in Trulicity, belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Other GLP-1 receptor agonists are available for managing type 2 diabetes, and they work by mimicking the effects of the GLP-1 hormone, which helps regulate blood sugar [1].
What are the potential side effects of Trulicity?
Common side effects of Trulicity include nausea, vomiting, diarrhea, abdominal pain, and decreased appetite. More serious side effects can occur, including pancreatitis, gallbladder problems, kidney problems, and allergic reactions [1].
Sources:
[1] https://www.drugpatentwatch.com/drugs/trulicity
[2] https://www.drugpatentwatch.com/trulicity-patent-expiration
[3] https://www.drugpatentwatch.com/patents-explained
[4] https://www.drugpatentwatch.com/biosimilars-explained
[5] https://www.drugpatentwatch.com/generic-drug-explained